ADORA2A and neoplasm: Inhibiting the adenosine receptor A2A—especially in the immune compartment—was able to reduce tumor initiation in a Braf/Pten mouse model, whereas direct adenosine stimulation promotes metastatic potential and outgrowth with no impact on primary tumor growth.